大脑中动脉分叉部动脉瘤经腔外血流导向装置治疗:中期血管造影演变与临床结局
该回顾性研究纳入2010年1月至2014年12月连续接受血流导向支架治疗的58例患者共63个大脑中动脉分叉部动脉瘤,随访至少12个月且至少2次控制血管造影。结果显示6个月时57例(98.3%)mRS 0-2分,12个月时95%的动脉瘤达到闭塞,动脉瘤破裂率为0%,作者认为血流导向装置似乎是复杂大脑中动脉分叉部动脉瘤的有效治疗选择,并发症率合理,但需要更长的血管造影随访来评估形态学结局。
要点
- 血流导向装置治疗后12个月95%的动脉瘤达到闭塞,动脉瘤破裂率为0%。
- 术后即刻仍显影的动脉瘤中68%在6个月进展为闭塞,95%在12个月进展为闭塞。
- 操作相关并发症发生率为8.6%(5/58),操作相关死亡率为0%。
核心结论
- 血流导向装置似乎是复杂大脑中动脉分叉部动脉瘤的有效治疗替代方案,并发症率合理;需要更长的血管造影随访来评估形态学结局,即刻次全闭塞似乎与破裂无关。
研究设计与样本
- 回顾性评估前瞻性维护的数据,连续纳入2010年1月至2014年12月接受血管内血流导向支架治疗的大脑中动脉分叉部动脉瘤患者58例共63个动脉瘤,所有患者随访至少12个月且至少2次控制血管造影,采用新的血流导向装置血管造影结局量表记录区域血流相关血管造影改变。
诊断标准与关键数值
- 从95%的术后即刻仍显影的血管造影结果中,68%在6个月进展为动脉瘤闭塞,95%在12个月进展为闭塞,动脉瘤破裂率为0%;操作相关并发症发生率为8.6%(5/58),操作相关死亡率为0%;治疗前mRS 0分12例(20.7%)、1分41例(70.7%)、2分5例(8.6%),6个月控制时mRS 0-2分57例(98.3%)、3分1例(1.7%);13个动脉瘤为大或巨大动脉瘤。
临床应用与阅片要点
- 作者认为血流导向装置似乎是复杂大脑中动脉分叉部动脉瘤的有效治疗替代方案,并发症率合理;需要更长的血管造影随访来评估形态学结局,即刻次全闭塞似乎与破裂无关。
局限性
- 需要更长的血管造影随访来评估形态学结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Flow diverters have been increasingly used lately in off-label, distal intracranial aneurysm treatments. Our aim was to evaluate the effectiveness of flow diverters in the treatment of middle cerebral artery bifurcation aneurysms and to analyze midterm angiographic patterns of regional flow modifications for safety and clinical outcomes.
MATERIALS AND METHODS: Consecutive patients treated from January 2010 to December 2014 by the authors by using endovascular flow-diverting stents for MCA bifurcation aneurysms were evaluated retrospectively with prospectively maintained data. All patients had been followed for at least 12 months after treatment, with at least 2 control angiograms; regional flow-related angiographic modifications were registered by using a new angiographic outcome scale for flow diverters. Data were analyzed with emphasis on procedure-related events, angiographic results, and clinical outcome.
RESULTS: Fifty-eight patients were included in the study, with 63 MCA bifurcation aneurysms; 13 of these were large and giant. Pretreatment mRS was 0 for 12 patients (20.7%), 1 for 41 (70.7%), and 2 for 5 patients (8.6%). Six-month control revealed mRS 0-2 for 57 (98.3%) patients and 3 for 1 (1.7%) patient. Procedure-related morbidity and mortality were 8.6% (5/58) and 0%, respectively. From 95% of still circulating immediate postprocedure angiographic outcomes, 68% progressed to aneurysm occlusion at 6 months and 95%, to occlusion at 12 months, with a 0% aneurysm rupture rate.
CONCLUSIONS: Flow diverters seem to be an effective treatment alternative for complex MCA bifurcation aneurysms, with reasonable complication rates. Longer angiographic follow-ups are needed to assess the morphologic outcome; immediate subtotal occlusions do not seem to be related to rupture.
引用
- Iosif C, Mounayer C, Yavuz K, et al. Middle Cerebral Artery Bifurcation Aneurysms Treated by Extrasaccular Flow Diverters: Midterm Angiographic Evolution and Clinical Outcome. AJNR Am J Neuroradiol. 2016. PMID: 27979794. doi:10.3174/ajnr.A5022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。